Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 10.15.2018
When Ebola virus disease (EVD) reared its head in May in the Congo, the world was armed with the rVSV-ZEBOV vaccine thanks to interagency collaboration efforts by the Defense Threat Reduction Agency’s Chemical and Biological Technologies Department....
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 10.15.2018
DNA-based nucleic acid vaccines have the potential to become a universal platform solution to viral threat agents. The U.S. Department of Defense is currently developing DNA vaccines to protect against a variety of viral threats including alphaviruses, filoviruses and hantaviruses....
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 10.15.2018
The Joint Science and Technology Office (JSTO) Science Review (JSR) fosters collaboration, cooperation and innovation by allowing program managers and senior leadership to understand the latest warfighter-driven technologies in development....
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 10.24.2017
Share innovative ideas with more than 1,500 of the most influential scientists, program managers and leaders in the defense community at the 2017 Chemical and Biological Defense Science & Technology (CBD S&T) Conference Nov. 28-30, 2017, in Long Beach, Calif....
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 12.14.2016
Warfighters face a variety of threats including chemical substances, such as chlorine, that have the potential to be turned into weapons. First discovered in 1774 and later used as a chemical weapon during World War I and the ongoing Syrian conflict, chlorine is one of the most commonly manufactured chemicals in the United States. Chlorine plays an integral role in our daily lives – from a......
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 06.30.2016
The development of novel catalysts and catalytic processes for Department of Defense chemical and biological defense applications is challenging. This challenge is largely due to a lack of detailed structure-function relationships necessary to drive the development of predictive capabilities toward new catalytic material design and catalyst process concepts capable of meeting current and......
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 06.30.2016
The U.S. Department of Defense is working to develop effective countermeasures against the pathogen melioidosis, a biowarfare agent, to better protect warfighters. Recent collaboration between the U.S. and Southeast Asia partners is addressing research gaps and prioritizing research avenues from this threat....
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 06.30.2016
Engineered by the Canadian weapons program in 1939, Botulinum neurotoxins (BoNTs), once known as Agent X, are some of the most lethal toxins available. Although Canada did not produce a biological weapon using BoNTs, the United States, Japan, Germany, former Soviet Union and Iraq successfully engineered BoNTs for use as a weapon of mass destruction....
